Endothelial dysfunction in COVID-19: A potential predictor of long-COVID?

The coronavirus disease of 2019 (COVID-19) pandemic has dominated everyday life around the globe for almost two years now. While effective COVID-19 vaccines became available just about one year after the discovery of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the breakthrough in medical treatment of patients with COVID-19 is still eagerly awaited. The incomplete understanding of the multifaceted pathophysiology of COVID-19 has hampered the development of targeted therapies to date.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research